Clinical Trial Update: A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-finding trial of AMG 531 for chemotherapy-induced thrombocytopenia in adults with lymphoma; the study completed and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• AMG 531 (AMG531)

Snippet

Sponsor: Amgen | Conditions: Chemotherapy-Induced Thrombocytopenia, Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-09-13